Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) has been given an average rating of “Moderate Buy” by the eleven research firms that are currently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $14.25.
A number of brokerages have recently issued reports on AVAH. JPMorgan Chase & Co. lifted their price objective on shares of Aveanna Healthcare from $8.00 to $15.00 and gave the company a “neutral” rating in a report on Monday, September 14th. Raymond James Financial reissued a “strong-buy” rating on shares of Aveanna Healthcare in a research report on Thursday, November 12th. UBS Group raised their price objective on Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research note on Friday, August 14th. Weiss Ratings upgraded shares of Aveanna Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research note on Friday, November 13th. Finally, Barclays upped their target price on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the stock an “overweight” rating in a research note on Friday, August 28th.
Read Our Latest Stock Analysis on Aveanna Healthcare
Aveanna Healthcare Stock Performance
NASDAQ AVAH opened at $10.70 on Friday. The company has a fifty day simple moving average of $12.82 and a 200 day simple moving average of $9.52. Aveanna Healthcare has a 12-month low of $5.93 and a 12-month high of $14.71. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 3.80. The company has a market cap of $2.34 billion, a P/E ratio of 7.81, a PEG ratio of 0.72 and a beta of 2.03.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings results on Thursday, November 12th. The company reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.02. Aveanna Healthcare had a net margin of 11.44% and a return on equity of 63.61%. The business had revenue of $695.54 million during the quarter, compared to analyst estimates of $679.48 million. Sell-side analysts predict that Aveanna Healthcare will post 0.75 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Aveanna Healthcare
Several large investors have recently made changes to their positions in AVAH. Littlejohn & Co. LLC purchased a new stake in Aveanna Healthcare in the 2nd quarter worth about $1,846,878. The Manufacturers Life Insurance Company bought a new stake in Aveanna Healthcare in the 2nd quarter valued at about $367,000. Man Group plc bought a new stake in Aveanna Healthcare in the 2nd quarter valued at about $1,043,000. Parkman Healthcare Partners LLC purchased a new stake in Aveanna Healthcare during the second quarter valued at about $6,123,000. Finally, Canada Pension Plan Investment Board purchased a new stake in Aveanna Healthcare during the second quarter valued at about $752,000. 87.96% of the stock is owned by hedge funds and other institutional investors.
Aveanna Healthcare Company Profile
Aveanna Healthcare Holdings Inc. is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities. The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.
See Also
- Five stocks we like better than Aveanna Healthcare
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
